Home > Boards > US Listed > Biotechs > Can-Fite BioPharma (CANF)

Roth Capital Reiterates Buy On Can-Fite w/ $20 pt...

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
~MulaGreen~ Member Profile
 
Followed By 1,136
Posts 36,258
Boards Moderated 0
Alias Born 03/26/07
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/6/2020 8:09:50 AM
Can-Fite Announces $3.4 Million Registered Direct Offering Business Wire - 7/6/2020 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/30/2020 7:08:57 AM
Can-Fite Announces Final Data Analysis from Phase II NASH Study: Business Wire - 6/30/2020 7:00:00 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 6/19/2020 4:36:29 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/19/2020 4:24:38 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/19/2020 6:03:47 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/12/2020 8:30:54 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/12/2020 8:04:03 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/10/2020 8:11:22 AM
Can-Fite Announces $8.0 Million Registered Direct Offering Business Wire - 6/10/2020 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/9/2020 7:05:20 AM
Following Pre-IND Guidance from FDA Can-Fite to Advance Piclidenoson into Phase II COVID-19 Trial in the U.S. Business Wire - 6/9/2020 7:00:00 AM
Can-Fite Participating in BIO Digital International Convention and One-on-One Partnering Meetings on June 8-12, 2020 Business Wire - 6/8/2020 7:25:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/4/2020 7:22:28 AM
Can-Fite Concludes Successful Meeting with European Medicines Agency (EMA) Regarding Phase III Trial & Registration Plan for ... Business Wire - 6/4/2020 7:14:00 AM
Can-Fite BioPharma to Hold Investor Webinar and Q&A Session with CEO on June 4th Business Wire - 6/3/2020 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 6/1/2020 7:24:12 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 6/1/2020 7:07:32 AM
Can-Fite Reports First Quarter 2020 Financial Results & Provides Clinical Update Business Wire - 6/1/2020 7:00:00 AM
Can-Fite to Host First Quarter 2020 Financial Results & Clinical Update Conference Call on June 1, 2020 Business Wire - 5/28/2020 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/21/2020 7:13:58 AM
Can-Fite Receives Notice of Allowance for Namodenoson Patent in the Treatment of NASH & NAFLD from U.S. Patent & Trademark Of... Business Wire - 5/21/2020 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 5/18/2020 7:09:21 AM
Can-Fite Reports Additional Findings from Successful Phase II NASH Study: 25 mg Dose of Namodenoson Significantly Reduced Liv... Business Wire - 5/18/2020 7:00:00 AM
~MulaGreen~   Saturday, 05/16/20 10:24:42 AM
Re: None
Post # of 1452 
Roth Capital Reiterates Buy On Can-Fite w/ $20 pt...

https://www.smarteranalyst.com/analyst-insights/roth-capital-reiterates-buy-can-fite-biopharma-following-recent-equity-raising/

and that was 6 years ago Moronic Pump!!!...ffwd to yesterday,this Little David BioTech from Gods Land...showed up @ the doorstep of the US FDA with Ph3 Piclidenoson Drug with proven efficacy and with very high % survival rate administered to CV-19 patients with moderate to severe cases ...begging for mercy to grant human trials and EUA here in the USA.

Imho,RC HC RnR and MG are getting ready to :Rewrite and Reiterate: their old and obsolete Pump & Blog as soon as they are finish suckkerring the cheapies once again...only this time...they have a Solid CV-19 ammo to support it.

Let's wait m see if they will reiterate a S-Buy and pt of $40 this time.
jmwhtto


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist